Grant Programs
Grants from the National Institutes of Health (NIH) as well as generous philanthropic support fund innovative research programs at the UCSF Brain Tumor Center.
Crosstalk between glioma cells and neurons is an untapped therapeutic target poised to have a significant impact on neuro-oncology.
This year marked the ninth cycle of Program Project Grant funding for the UCSF Brain Tumor Center from the NIH. The Center’s first Program Project Grant was awarded in 1979 to study the biology and therapy of malignant brain tumors.
Under this program, five cutting-edge projects explore bold avenues to potentially advance treatment for malignant glioma.
Specialized Programs of Research Excellence (SPOREs), designated and funded by the National Cancer Institute since 1992, are intended to promote translational research focused on an organ-specific human cancer. UCSF is one of six institutions to be awarded a SPORE grant for brain tumors.
The UCSF Wolfe Meningioma Program Project brings together UCSF’s leading clinicians and scientists to solve the problems that currently limit our ability to understand meningioma biology and provide more effective therapy to meningioma patients.
The lower grade glioma research collective (loglio) is a coalition of investigators dedicated to improving diagnosis and treatment for lower grade glioma.